Table 4. Pre- and post-treatment differences in patients.
Before testosterone treatment (n: 19) | After testosterone treatment (n: 19) | p | Before hCG treatment (n: 17) | After hCG treatment (n: 17) | p | |
---|---|---|---|---|---|---|
Total testosterone (ng/dL) † | 60 [86] | 400 [234] | <0.001 a | 36 [31] | 384 [220] | <0.001 a |
Estradiol (pg/mL) * | 29.9 ± 2.2 | 29.5 ± 2.4 | 0.149 b | 20.6 ± 2.5 | 40.8 ± 1.9 | <0.001 b |
Total testosterone to estradiol ratio ([ng/dL]/[pg/mL]) † | 1.8 [2.9] | 13.3 [9] | <0.00 a | 1.6 [1.5] | 9.1 [6] | <0.00 a |
Morning erections (≥3/week), (n, %) | 0 (0%) | 10 (58.8%) | 0.002 a | 0 (0%) | 6 (35.3%) | 0.014 a |
Right Mean testicular volume (mL) † | 1.6 [2.5] | 1.8 [2.2] | 0.110 a | 1.0 [5.8] | 2.5 [6.5] | <0.001 a |
Left Mean testicular volume (mL) † | 1.6 [1.9] | 1.8 [3.4] | 0.008 a | 1.1 [6.3] | 2.8 [7.5] | <0.001 a |
Lumbar Z score † | -2.9 [1.2] | -2.2 [0.9] | <0.001 a | -2.7 [1.5] | -2.1 [0.7] | <0.001 a |
hCG: human chorionic gonadotropin.
Wilcoxon signed ranks test.
Paired samples t-test.
Data are presented as mean ± standard deviation (SD).
Data are presented as median (interquartile range [IQR]).